Lawrence E. Morris

T-Cell–Replete HLA-Haploidentical Hematopoietic Transplantation for Hematologic Malignancies Using Post-Transplantation Cyclophosphamide Results in Outcomes Equivalent to Those of Contemporaneous HLA-Matched Related and Unrelated Donor Transplantation

Asad Bashey, Xu Zhang, Connie A. Sizemore et al. · Journal of Clinical Oncology · 2013 · 495 citations

CTLA4 blockade with ipilimumab to treat relapse of malignancy after allogeneic hematopoietic cell transplantation

Asad Bashey, Bridget Medina, Sue Corringham et al. · Blood · 2008 · 364 citations · Full text

Haploidentical Transplantation Using T Cell Replete Peripheral Blood Stem Cells and Myeloablative Conditioning in Patients with High-Risk Hematologic Malignancies Who Lack Conventional Donors is Well Tolerated and Produces Excellent Relapse-Free Survival: Results of a Prospective Phase II Trial

Scott R. Solomon, Connie A. Sizemore, Melissa Sanacore et al. · Biology of Blood and Marrow Transplantation · 2012 · 296 citations · Full text

Nonmyeloablative HLA-Haploidentical Bone Marrow Transplantation with High-Dose Posttransplantation Cyclophosphamide: Effect of HLA Disparity on Outcome

Yvette L. Kasamon, Leo Luznik, Mary S. Leffell et al. · Biology of Blood and Marrow Transplantation · 2009 · 278 citations · Full text

Double unrelated umbilical cord blood vs HLA-haploidentical bone marrow transplantation: the BMT CTN 1101 trial

Ephraim J. Fuchs, Paul V. O’Donnell, Mary Eapen et al. · Blood · 2020 · 203 citations · Full text